Great Lakes Advisors, LLC Revance Therapeutics, Inc. Transaction History

Great Lakes Advisors, LLC

  • $11.1 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 08, 2024
BUY
$5.81 - $11.2 $69,028 - $133,067
11,881 Added 5.35%
233,958 $2.06 Million
Q3 2023

Nov 07, 2023
BUY
$11.47 - $25.07 $307,246 - $671,550
26,787 Added 13.72%
222,077 $2.55 Million
Q2 2023

Aug 10, 2023
SELL
$24.7 - $37.61 $2.58 Million - $3.93 Million
-104,611 Reduced 34.88%
195,290 $4.94 Million
Q1 2023

May 10, 2023
BUY
$18.36 - $35.27 $5.51 Million - $10.6 Million
299,901 New
299,901 $9.66 Million

Others Institutions Holding RVNC

# of Institutions
234
Shares Held
82.8M
Call Options Held
680K
Put Options Held
896K
View Full List

About Revance Therapeutics, Inc.

RVNC Quotes by TradingView
  • Ticker RVNC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 82,305,696
  • Market Cap $212M
  • Description
  • Revance Therapeutics, Inc., a biotechnology company, engages in the development, manufacture, and commercialization of neuromodulators for various aesthetic and therapeutic indications in the United States and internationally. The company's lead drug candidate is DaxibotulinumtoxinA for injection, which has completed phase III clinical trials fo...
More about RVNC
Track This Portfolio

Track Great Lakes Advisors, LLC Portfolio

Follow Great Lakes Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Great Lakes Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Great Lakes Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email